BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Has $13.50 Million Holdings in Colgate-Palmolive (NYSE:CL)

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp cut its stake in Colgate-Palmolive (NYSE:CLFree Report) by 13.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 130,054 shares of the company’s stock after selling 19,733 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp’s holdings in Colgate-Palmolive were worth $13,501,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. NCM Capital Management LLC acquired a new position in shares of Colgate-Palmolive in the 3rd quarter worth approximately $203,000. Captrust Financial Advisors grew its position in Colgate-Palmolive by 4.6% during the 3rd quarter. Captrust Financial Advisors now owns 112,489 shares of the company’s stock worth $11,677,000 after acquiring an additional 4,995 shares during the last quarter. Kingfisher Capital LLC grew its position in Colgate-Palmolive by 1.4% during the 3rd quarter. Kingfisher Capital LLC now owns 11,036 shares of the company’s stock worth $1,146,000 after acquiring an additional 156 shares during the last quarter. Rockefeller Capital Management L.P. grew its position in Colgate-Palmolive by 0.7% during the 3rd quarter. Rockefeller Capital Management L.P. now owns 2,165,600 shares of the company’s stock worth $224,806,000 after acquiring an additional 14,032 shares during the last quarter. Finally, CWS Financial Advisors LLC grew its position in Colgate-Palmolive by 11.5% during the 3rd quarter. CWS Financial Advisors LLC now owns 3,195 shares of the company’s stock worth $332,000 after acquiring an additional 329 shares during the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CL has been the topic of a number of research analyst reports. Wells Fargo & Company decreased their price target on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating on the stock in a research report on Monday, October 28th. Deutsche Bank Aktiengesellschaft lowered Colgate-Palmolive from a “buy” rating to a “hold” rating and increased their price target for the stock from $107.00 to $109.00 in a research report on Monday, September 9th. UBS Group increased their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. JPMorgan Chase & Co. increased their price target on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Finally, TD Cowen decreased their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $105.11.

Get Our Latest Research Report on CL

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Stock Down 0.1 %

NYSE:CL opened at $96.63 on Friday. Colgate-Palmolive has a 12-month low of $75.50 and a 12-month high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The firm has a market capitalization of $78.95 billion, a P/E ratio of 27.69, a P/E/G ratio of 3.45 and a beta of 0.42. The stock’s fifty day simple moving average is $97.38 and its 200-day simple moving average is $98.61.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were paid a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 2.07%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s payout ratio is presently 57.31%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.